Introduction
Managing chronic wounds constitutes a major health issue for the 21st century, and consumes signifi cant amounts of healthcare funding. [ 1 ] The presence of bacteria in chronic wounds is unavoidable, but certain bacteria and their biofi lms delay wound healing and cause serious infections extending into the underlying bone or even systemic septicemia, with grave consequences for the patient. [ 2 ] Two of the most common
In this study, we designed and developed a biosensor for SrtA to indirectly detect the presence of bacteria S. aureus. The biosensor was designed based on a porous silicon resonant microcavity (pSiRM) structure modifi ed with a specifi c Förster (fl uorescence) resonance energy transfer (FRET) peptide substrate containing the LPXTG motif. We used the SrtA substrate sequence, Dnp-LPETG-(K-FITC)-NH 2 , containing 2,4-dinitrophenol (Dnp) as a quencher, fl uorescein isothiocyanate (FITC) as a fl uorescent dye, and an amino group to covalently anchor the substrate to the pores of the pSiRM. In the presence or SrtA, the peptide is cleaved and Dnp is removed, leaving FITC bound to the pSiRM. SrtA detection was performed in Hepes buffer solution and in complex samples, namely human wound fl uid and bacterial culture medium. We also demonstrated the multiplexing capability of the pSiRM sensing platform by detecting metalloproteinases (MMPs) and SrtA in parallel ( Figure 1 ).
Results and Discussion

Design, Fabrication and Characterization of pSiRM Sensing Platform
The sensing platform used to detect SrtA was based on a photonic pSiRM structure. The pSiRM structure has an active cavity layer in between two distributed Bragg refl ectors (DBR) of alternating high porosity (HP) and low porosity (LP) layers. This architecture produces a characteristic optical spectrum with a narrow photonic resonance dip in the stop band of Bragg refl ectors. The enhancement in photoluminescence from the pSiRM structure is based on a spontaneous emission of the emissive substance inside the active layer of the pSiRM, which is known as the Purcell effect. [ 11 ] This effect is related to the local density of optical states in microcavities or plasmonic resonances. [ 11b ] When pore size, porosity contrast, incident angle, and wavelength alignment of the photonic bandgap are tuned, sensitive biosensor platforms can be designed.
The pSiRM used in this study was based on our previously reported confi guration of (HP/LP) 3 (HP) 4 (LP/HP) 3 . [ 12 ] The HP layer was etched at a current density of 50 mA cm −2 for 2658 ms producing pore diameters ranging from 110 to 140 nm and 83.4% porosity, while the LP layer was etched at a current density of 25 mA cm −2 for 2237 ms resulting in pore diameters ranging from 40 to 60 nm and 67% porosity. These conditions were designed to accommodate SrtA molecules which have unit cell dimensions of 9 nm × 9 nm × 25 nm. [ 13 ] The pore size and porosity contrast were chosen to optimize infi ltration of the biomolecules and the sensitivity of the pSiRM sensing platform. [ 12, 14 ] The pore size of both HP and LP layers has to be large enough to allow infi ltration of SrtA, and the porosity contrast between HP and LP has to be considered in order to design a sensitive pSiRM biosensing platform. [ 12 ] Those two parameters infl uence the effective refractive index, while the refractive index contrast between HP and LP layers affects the optical features of the pSiRM. [ 15 ] In addition to that, the Q factor, which is defi ned as the ratio of the central resonance wavelength and the full width at half maximum (FWHM), is also crucial because it indicates the effectiveness of light confi ned in the active layer of the microcavity. [ 16 ] Ouyang and Fauchet found that a high Q factor value indicates the more effi cient light confi nement inside of the microcavity, resulting in more effective fl uorescence enhancement. [ 17 ] However, based on our previous study, increasing the Q factor does not necessarily mean higher sensitivity of the biosensor. [ 12 ] Our microcavity needed to produce a dip in the refl ectance spectrum at a wavelength (λ) of 514 nm, aligned with the emission wavelength of the FITC dye. An aligned microcavity facilitates fl uorescence emission enhancement of the fl uorophore located within the pSiRM structure. To achieve that effect, we considered the wavelength shifts during the fabrication and surface modifi cation steps. The refl ectance spectrum of the pSiRM was fi rst simulated using the transfer matrix method to obtain a dip at 514 nm with an angle of 36° in accordance with the angle during the fl uorescence measurement set for maximum fl uorescence emission. [ 12 ] When this microcavity was fabricated as per the conditions from the simulation, the refl ectance spectrum showed an 8 nm redshift. An additional 7 nm redshift was obtained after surface modifi cation. Therefore, to compensate for those shifts and to produce the fi nal wavelength of the microcavity dip at 514 nm after surface modifi cation, the pSiRM was simulated for a dip located at 499 nm at a 36° angle.
In the simulation, the refractive indices ( n ) were 1.3 and 1.7 for the HP and LP layers, respectively. These n values combined with the λ of the designed microcavity dip were used to determine the thickness of each periodic layer considering the λ /4 rule for each DBR and λ /2 rule for the defect layer. This condition formed a 96 nm thick HP layer and a 73 nm thick LP layer. The total thickness of the pSiRM structure was 1.4 µm. Refl ectance spectroscopy and scanning electron microscopy (SEM) were used to characterize the position of the microcavity dip and the morphology of the pSiRM, respectively ( Figure 2 ). The refl ectance spectrum of freshly etched pSiRM (Figure 2 a) shows that the position of the freshly etched microcavity dip was at 507 nm at an angle of 36° or redshifted about 8 nm from the simulation (499 nm). The top view (Figure 2 b) SEM image shows that the pore diameter ranged from 110 to 140 nm (the fi rst layer or HP layer) and the cross-section (Figure 2 c) SEM image shows that the thickness was around 1.4 µm, which is in agreement with the Scout simulation.
Surface Functionalization of the pSiRM
The modifi cation of the pSiRM surface was essential for the stabilization and immobilization of peptide molecules on the pSiRM sensing platform. [ 18 ] Here, hydrosilylation was used to modify the pSiRM. [ 18b , 19 ] Thermal hydrosilylation of neat undecylenic acid on the pSiRM surface formed a dense alkyl monolayer with stable Si C bonds, preventing the pSiRM surface from undergoing oxidative hydrolysis. [ 19c , 20 ] The alkyl monolayer contained a distal carboxylic acid group, which can be activated in the form of succinimidyl esters to react with amino groups on the fl uorogenic SrtA peptide substrate. The surface modifi cation steps were monitored by means of FTIR spectroscopy in the attenuated total refl ection (ATR) mode ( Figure S1 , Supporting Information).
The surface modifi cation steps were also followed optically using refl ectance spectroscopy to monitor the wavelength shift of the microcavity dip. After the hydrosilylation reaction, the position of the microcavity dip shifted 5.0 nm to longer wavelength (redshift). This shift was due to the additional long alkyl chain on the pSiRM surface. The activation of hydrosilylated surface using EDC/NHS also redshifted the dip position by 1.0 nm. These shifts were consistent with our previous results using the same surface modifi cation reaction. [ 12 ] The immobilization of SrtA substrate redshifted the microcavity dip by 1.2 nm. These gave a total redshift of 7.2 nm for the whole modifi cation process.
Biosensor Principle
Upon incubation with SrtA at 4.6 × 10 −8 M, the position of the microcavity dip shifted 0.5 nm to the shorter wavelength (blueshift), indicating that a fraction of the peptide immobilized on the pSiRM surface was indeed cleaved ( Figure 3 a) . Thus, changes due to immobilization of SrtA substrate and its subsequent cleavage caused by Srt A gave a total shift of 6.7 nm which needs to be considered when designing the position of microcavity pSiRM. Note that for lower SrtA concentrations than 4.6 × 10 −8 M, blueshifts in the refl ectance spectra were not observable after incubation of the pSiRM.
We thus investigated if FITC fl uorescence from the pSiRM surface upon cleavage of the Dnp quencher and the fl uorescence enhancement effects in the aligned pSiRM would translate into improved sensitivity of detection. [ 21 ] The SrtA peptide-modifi ed pSiRM surface was incubated with 4. The strong FITC emission after SrtA cleavage of the SrtA substrate immobilized on the pSiRM surface was 13-fold higher than that detected upon cleavage of the SrtA substrate in solution (Figure 3 b) . In addition to that, the emission peak of the FITC dye in solution (FWHM ≈ 36 nm) was nine times broader than the FITC emission peak from the pSiRM surface (FWHM ≈ 4 nm). The fl uorescence emission from different pSi structures (single layer with LP, single layer with HP and multilayer) and untuned pSi were compared ( Figure S2 , Supporting Information). Taken together, our results confi rm the fl uorescence enhancement effect of the pSiRM sensing platform and the confi nement effect of light that escapes from the microcavity surface. [ 21, 22 ] 
Biosensor Performance
The performance characteristics of the developed biosensor were investigated. First, studies of the effect of the incubation time on fl uorescence emission signal were performed. The incubation of 4.6 × 10 −8 M SrtA on the SrtA peptide-modifi ed pSiRM with the tuned cavity wavelength ( Figure S3 , Supporting Information) showed that after 5 min incubation time, a conspicuous fl uorescence emission signal appeared, indicating that the SrtA substrate was already being cleaved and reached a maximum with incubation time up to 30 min, which is in agreement with previously reported results. [ 23 ] Therefore, further experiments were performed with an incubation time of 30 min. [ 24 ] demonstrating its potential as a point-of-care diagnostic tool.
SrtA Detection in Human Wound Fluid and Bacterial Culture
We also demonstrated the capability of the pSiRM sensing platform to detect the presence of SrtA in complex biological samples, such as human chronic wound fl uid and bacterial culture medium ( Figure 4 ; Figures inoculation times, the concentration of S. aureus was 2.1 × 10 8 , 5.1 × 10 8 , 1.1 × 10 9 , and 2.6 × 10 9 CFU mL −1 , respectively. Incubating the solutions with increasing bacteria concentrations on the pSiRM gave rise to increasing fl uorescence intensity. This was expected since S. aureus growth leads to increased SrtA concentration in wound bed as observed by Yarets et al. [ 25 ] FITC fl uorescence emission was also detected in human wound fl uid inoculated for 24 h with S. aureus and then fi ltered. Comparing wound fl uid and bacterial culture medium for the same inoculation time, the wound fl uid sample showed lower fl uorescence intensity, indicating that the bacterial growth in the culture medium is faster than in the wound fl uid. This is expected since the culture medium has optimum conditions for bacterial growth. However, our sensing platform was still able to detect SrtA directly in the wound fl uid sample.
We also studied matrix effects that may be caused by other biomolecules in wound fl uid or bacterial culture medium. Fluorescence emission of human wound fl uid and bacterial media, with and without S. aureus (24 h inoculation time) was determined after spiking with 4.6 × 10 −8 M , 4.6 × 10 −10 M and 4.6 × 10 −12 M SrtA ( Figure 5 ).
The fl uorescence signal generated on the pSiRM samples exposed to either wound fl uid, bacterial culture media, wound fl uid inoculated with S. aureus for 24 h, or bacterial culture medium inoculated for 24 h containing SrtA showed linear relationships with the concentration of SrtA. The percentage of slope deviation between calibration curves for each one of the biological samples and for spiked buffer samples was in all cases less than 1%, indicating the absence of matrix effect. The offset of the lines is related to the initial SrtA concentration in each complex matrix (wound fl uid and bacterial culture medium with and without 24 h S. aureus inoculation).
The biosensor described here has the potential to become a diagnostic tool of wound status affording rapid medical assessment that can be used to guide treatment actions, such as adding topical antibiotics in response to the detection of bacterial infection. In particular, this tool could be deployed as a point-of-care diagnostic device of wound exudates able to provide fast, sensitive, and selective response of S. aureus infection. Recently, we reported a MMP biosensor for the detection of MMP-1 also based on the fl uorescence enhancement effect achieved using pSiRM. [ 12 ] MMP-1 is produced by cells approximately 1 week after wounding or at the postacute stage of healing. [ 26 ] While the MMP biosensor that we recently reported provides accurate information by monitoring the changes in the levels of MMP-1 after wounding and during the healing process, our SrtA biosensor confi rms bacterial infection by means of discrete detection of this bacterial enzyme. In addition, our study is the fi rst demonstration of multiplexed detection, which is expected to translate into a biosensor that it useful from a clinical perspective since it can distinguish different types of enzymes present in the wound environment.
Fluorescence Detection Using Confocal Microscopy
To demonstrate that fl uorescence microscopy can be used to qualitatively observe the presence of SrtA on the pSiRM sensing platform, one half of the pSiRM sample was functionalized with SrtA peptide substrate (sample surface) and the other was left unmodifi ed. This was achieved by masking with PDMS during surface functionalization.
The confocal microscopy image in Figure 6 b shows the boundary between the regions with and without peptide substrate upon exposure to SrtA as green-fl uorescing (FITC intensity emission shown in Figure 6 a) and dark, respectively.
On the basis of this result, an array of peptide spots was produced on a pSiRM sample via robotic printing of two different fl uorogenic peptide substrates to explore the multiplexing possibility of the biosensor. One peptide was specifi c for MMPs and the other for SrtA. The peptide substrates were printed on the activated pSiRM surface following the pattern shown in Figure 7 featuring spots of 350 µm diameter. The array on the pSiRM surface was incubated with human wound fl uid and bacterial culture medium samples, respectively. Note that the presence of MMP-1 in the wound fl uid sample was confi rmed using Western blotting. [ 27 ] The pSiRM surface incubated with wound fl uid showed only blue fl uorescence emitted from the rows of MMP peptide substrate spots corresponding to the emission of EDANS dye upon cleavage of the MMP-specifi c peptide substrate with the sequence Dabcyl-Gaba-Pro-Gln-Gly-LeuGlu(EDANS)-Ala-Lys-NH 2 . These confocal images corroborate the presence of MMPs and the absence of SrtA in the wound fl uid sample. The pSiRM surface incubated with bacterial culture medium after 24 h inoculation showed green FITC fl uorescence emitted from the rows containing SrtA peptide substrate spots. These experiments corroborate that the SrtA present in bacterial culture medium sample did not cleave the MMP peptide substrate and vice versa, and effectively demonstrate the selectivity of the peptide substrate immobilized on the pSiRM. 
Conclusion
In conclusion, we have demonstrated the detection of SrtA bacterial enzyme by utilizing a pSiRM modifi ed with a fl uorogenic SrtA peptide substrate. The fl uorescence-based SrtA detection can be achieved using either a fl uorometer or a confocal microscope. A pSiRM array modifi ed with SrtA and MMP peptide substrates was prepared to demonstrate selective and multiplexed biomarker detection. These results confi rm that the fl uorogenic peptide-modifi ed pSiRM sensing platform holds strong potential for further development as a point-of-care device for the management of chronic wounds.
Experimental Section
Materials : All pSiRM samples were prepared from phosphorus doped n-type Si wafers, (100)-oriented, 0.008-0.02 Ω cm resistivity (Siltronix). The Si wafers were cut into a size of 3-4 cm 2 using a diamond cutter. All chemicals were purchased from Sigma-Aldrich unless otherwise stated. High purity solvents (methanol, ethanol, acetone, and dichloromethane) were purchased from Chem Supply. The S. aureus SrtA enzyme with the molecular weight of 27.1 kDa was purchased from BPS Bioscience. The SrtA peptide substrate, Dnp-LPETG-(K-FITC)-NH 2 , was synthesized by Mimotopes Ltd Pty, Melbourne, Australia. The MMP substrate, Dabcyl-Gaba-Pro-Gln-Gly-LeuGlu(EDANS)-Ala-Lys-NH 2 , was purchased from Merck. Cold fi lterable tryptone soya broth (Oxoid) and nutrient agar (Oxoid) were purchased from ThermoFisher Scientifi c Australia and prepared as per the manufacturer's instructions.
Design, Fabrication and Characterization of the pSiRM Sensing Platform : The pSiRM samples were fabricated in a Tefl on-based electrochemical etching cell. The back of the Si wafer was contacted with an aluminum sheet and a platinum mesh was used as a cathode. A current source meter (Keithley 2425, USA) was connected to these electrodes. The electrochemical etching solution contains 25:200:1 volume ratio of hydrofl uoric acid (48%, Scharlau)/ water/surfactant (NCW1001, Wako Pure Chemical Industries).
[ 14b ] The parasitic layer of Si wafer was removed by anodically etching Si wafer at a current density of 40 mA cm −2 for 30 s, followed by a high current density etch of 250 mA cm −2 for 6 s which led to surface electropolishing. The electropolished surface was exposed to MilliQ water for 1 min to remove the sacrifi cial layer, then washed with methanol, acetone, dichloromethane and dried under a stream of nitrogen gas.
The pSiRM structure used in this study had a confi guration of (HP/LP) 3 (HP) 4 (LP/HP) 3 . The alternating layers of different porosity were fabricated by anodically etching the pretreated Si wafer at 50 mA cm −2 for 2568 ms and at 25 mA cm −2 for 2237 ms, corresponding to HP and LP layers, respectively. The defect layer was etched at current density of 50 mA cm −2 for 10272 ms. The pSiRM was optically characterized using refl ectance spectroscopy. The morphology of the resulting structure was characterized by scanning electron microscopy (SEM), using a Quanta 450 fi eld emission gun (FEG) environmental SEM fi tted with a solid-state detector (SSD) and an accelerating voltage of 30 kV.
Surface Modifi cation and Characterization : The freshly etched pSiRM samples were thermally hydrosilylated using neat undecylenic acid in a glass reaction fl ask. The neat undecylenic acid was purged with argon for 15 min to remove any oxygen. The freshly etched pSiRM samples were then immersed in undecylenic acid and purged for a further 30 min. The glass reaction fl ask was immersed in an oil bath at 120 °C. The reaction was performed for 3 h under argon fl ow. Afterward, the hydrosilylated pSiRM samples were removed from the fl ask, rinsed with ethanol and dried under a stream of nitrogen gas.
The hydrosilylated pSiRM samples were activated by reacting with N-hydroxysuccinimide (NHS, Sigma-Aldrich) (5 × 10 reaction was conducted for 20 min at room temperature in a horizontal shaker. Afterward, the activated pSiRM samples were rinsed with water and dried under a stream of nitrogen gas. The SrtA peptide substrate was immobilized on the activated pSiRM surface by overnight incubation of 1 × 10 −3 M SrtA substrate in 50 × 10
Hepes buffer (pH 7.4) containing 150 × 10 −3 M NaCl, 5 × 10 −3 M CaCl 2 , and 5 × 10 −3 M glycine (Gly) (Hepes buffer). Afterward, the surface was rinsed with water, 2:1 water/ethanol, 1:2 water/ethanol and ethanol and then dried under a stream of nitrogen gas. Before using as a sensing platform, the modifi ed surface was blocked with 1 M ethanolamine pH 8.5 for 10 min to prevent unspecifi c binding. This SrtA peptide-modifi ed pSiRM was then used as the pSiRM sensing platform during the sensing experiments.
Fourier-transform infrared spectroscopy (FTIR) was used to characterize the surface after each step of the surface modifi cation. All FTIR samples were prepared from p-type Si wafer with a resistivity of 0.00055-0.001 Ω cm etched at a current density of 56 mA cm −2 for 2 min. The FTIR spectra were obtained using a Vertex 70 Hyperion microscope (Bruker) in the attenuated total refl ection (ATR) mode, recorded over the range of 650-4000 cm −1 , at a resolution of 22 cm −2 , an aperture size of 3 mm and averaging 64 scans. The baseline was corrected and normalized with OPUS 7.2 Spectroscopy Software (Bruker).
Biosensor Experiments : The SrtA peptide-modifi ed pSiRM sensing platform was incubated with SrtA enzyme at varying concentration (4.6 × 10 −8 M to 4.6 × 10 −18 M) at 30 °C [ 23, 26 ] for different incubation time (0, 5, 10, 15, 30, and 60 min) and then rinsed with water, 2:1 water/ ethanol, 1:2 water/ethanol and ethanol. The pSiRM sensing platform was then dried under a stream of nitrogen gas and placed in a fl uorometer cuvette with a sample holder to support the surface. In the fl uorometer (Parkin Elmer LS 55 Luminescence Spectrometer), the pSiRM surface was placed at an angle of 36° in respect to the surface normal. [ 12 ] The fl uorescence emission was measured over a wavelength range of 500-600 nm at a fi xed excitation wavelength of 495 nm, excitation and emission slit width of 5 nm each and a scan speed of 200 nm min S. aureus was streak-plated on nutrient agar plates and incubated at 37 °C to obtain individual colonies. Individual colonies were subcultured in tryptone soya broth (TSB) as bacterial culture medium and inoculated for 0, 0.5, 1, 3, 5, and 24 h. Cell-free culture medium was obtained by fi ltering the culture using a sterile 0.22 µm fi lter. Individual colonies were also subcultured in wound fl uid and inoculated for 24 h.
During sensing, the SrtA peptide-modifi ed pSiRM sensing platform was incubated with the biological sample for 30 min at 30 °C. Afterward, the surface was rinsed and dried before fl uorescence measurement using the same condition as described above.
Biosensor Characterization Using Confocal Microscopy : Confocal microscopy was used to image the fl uorescence emission of the pSiRM surface. A PDMS mask was used to protect half of the hydrosilylated pSiRM surface during covalent binding of the SrtA peptide substrate. The surface was then observed using a Carl Zeiss LSM 710 confocal microscope with an EC Plan-Neofl uar 10×/0.30 M27 objective. The surface was illuminated with light of a wavelength of 495 nm to collect the fl uorescence micrograph with an emission range of 510-560 nm.
pSiRM Microarray : We also prepared a pSiRM array to immobilize two different fl uorogenic peptide substrates. The activated pSiRM surface was printed using a SciFlexarrayer -S3 Microarray (Scienion). Two rows, with fi ve spots each, were printed with 20 nL per spot of 10 × 10 −3 M MMP fl uorogenic peptide substrate solution, and the other two rows, also printed with fi ve spots each, were modifi ed with 20 nL per spot of 1 × 10 −3 M SrtA fl uorogenic peptide substrate solution. This array was incubated with human chronic wound fl uid and bacterial culture medium before imaging using a confocal microscope. The surface was illuminated with light of a wavelength of 495 nm to monitor the fl uorescence emission at a range of 510-560 nm from the spots immobilized with SrtA substrate and at 340 nm to monitor the fl uorescence emission at a range of 435-485 nm from MMP peptide substrate.
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